VENTRIBIO
LIVE

Serial Number

98807728

Owner

VENTRIBIO, besloten vennootschap

Attorney

Clifford D. Hyra

Filing Date

Oct 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

VENTRIBIO Trademark

Serial Number: 98807728 • Registration: 7843952

VENTRIBIO is a trademark filed by VENTRIBIO, besloten vennootschap on October 17, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

VENTRIBIO, besloten vennootschap

Berkenbroekstraat 1
Bree 3960 , BE

Entity Type: 99

Trademark Details

Filing Date

October 17, 2024

Registration Date

June 24, 2025

Published for Opposition

May 6, 2025

Goods & Services

Pharmaceutical preparations for the prevention and treatment of gastrointestinal conditions, musculo-skeletal conditions and joint diseases; vaccines; dietary supplements; nutritional supplements; dietetic preparations adapted for medical use, namely, gastro-intestinal treatment preparations; food supplements for human consumption in the form of tablets and capsules; pharmaceutical products for human use in the form of tablets and capsules for the prevention and treatment of gastrointestinal conditions, musculo-skeletal conditions and joint diseases; probiotic supplements; prebiotic supplements; food supplements for human consumption; nutraceutical preparations for therapeutic or medical purposes for the prevention and treatment of gastrointestinal conditions, musculo-skeletal conditions and joint diseases; stem cells for medical purposes; pharmaceutical preparations containing stem cells for the treatment of genetic diseases in the nature of single-gene disorders, immunological diseases and cancer; cell growth media for growing cells for medical use; cells for medical or clinical use; personalized cell therapies, namely, stem cells for medical use; pharmaceutical preparations and substances for the treatment of genetic diseases and immunological diseases; pharmaceutical preparations and substances for applications in tissue engineering and regenerative medicine; blood plasma; antibacterial gels; body gels for pharmaceutical use for the treatment of burns, acne, allergic reactions, eczema, dermatitis, psoriasis, and viral, bacterial and fungal skin infections

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 24, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 24, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 6, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 6, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 7, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 31, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 31, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 31, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 31, 2025 CNEA
ASSIGNED TO EXAMINER
Mar 24, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2024 NWOS
NEW APPLICATION ENTERED
Oct 17, 2024 NWAP